(Q35984291)

11 August 2017

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer (English)

1 reference

11 August 2017

1 reference

Bianco AR

1

1 reference

11 August 2017

Del Mastro L

2

1 reference

11 August 2017

Gallo C

3

1 reference

11 August 2017

Perrone F

4

1 reference

11 August 2017

Matano E

5

1 reference

11 August 2017

Pagliarulo C

6

1 reference

11 August 2017

De Placido S

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 1991

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

63

1 reference

11 August 2017

5

1 reference

11 August 2017

799-803

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.177

11 August 2017

0 references

cites work

A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

Evaluation of survival data and two new rank order statistics arising in its consideration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

Mechanism of action of adjuvant chemotherapy in early breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

Analysis of survival by tumor response.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

Ovarian function and adjuvant chemotherapy for early breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972375

The role of prophylactic castration in the therapy of human mammary cancer

11 July 2018

1 reference

12 December 2020

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

1 reference

12 December 2020

Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients

1 reference

12 December 2020

Prophylactic oophorectomy in operable instances of carcinoma of the breast

1 reference

12 December 2020

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer

1 reference

12 December 2020

Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.177

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

2039706

1 reference